The effects of milrinone and dobutamine upon BNP levels in patients with NYHA-class IV decompensated heart failure

被引：0
|
作者：
Pontes-Arruda, A [1 ]
机构：
[1] Fernandes Tavora Hosp, Dept Intens Care, Fortaleza, Ceara, Brazil
来源：
CRITICAL CARE MEDICINE | 2005年 / 33卷 / 12期
关键词：
D O I：
10.1097/00003246-200512002-00199
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [1] Quality of life, anxiety and depression dependent on NYHA-class in patients with chronic heart failure
    Jünger, J
    Krämer, S
    Schellberg, D
    Habich, A
    Zugck, C
    Haass, M
    Herzog, W
    [J]. PSYCHOSOMATIC MEDICINE, 1998, 60 (01) : 106 - 107
  • [2] Use of dobutamine and milrinone in decompensated heart failure patients at a university teaching hospital.
    Cooper, JB
    Montague, D
    Rodgers, JE
    Patterson, JH
    [J]. PHARMACOTHERAPY, 2002, 22 (10): : 1333 - 1333
  • [3] Repetitive Therapy with Levosimendan Effectively Reduces NT-proBNP Levels and NYHA-Class in Heart Failure Patients A Case Report
    Wechsler, Maximilian
    Schwinger, Robert H. G.
    [J]. AKTUELLE KARDIOLOGIE, 2022, 11 (05) : 484 - 489
  • [4] Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels
    Hai-Yan Pan
    Jian-Hua Zhu
    Yong Gu
    Xiao-Hong Yu
    Min Pan
    Hong-Yin Niu
    [J]. BMC Cardiovascular Disorders, 14
  • [5] Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels
    Pan, Hai-Yan
    Zhu, Jian-Hua
    Gu, Yong
    Yu, Xiao-Hong
    Pan, Min
    Niu, Hong-Yin
    [J]. BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [6] ADDITIVE EFFECTS OF MILRINONE AND DOBUTAMINE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    MEISSNER, A
    HERRMANN, G
    GERDESMEYER, L
    SIMON, R
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1992, 81 (05): : 266 - 271
  • [7] Superiority of plasma BNP to echocardiography in assessing the impact of therapy upon NYHA class in a heart failure clinic
    Lee, SC
    Sandberg, SM
    Heublein, DM
    Nelson, SM
    Redfield, MM
    Burnett, JC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 181A - 182A
  • [8] Acute therapy with Levosimendan (Simdax®) in decompensated heart failure NYHA IV
    Hardut, D.
    Eisenkoelbl, J.
    Elliott, P.
    Zweng, A.
    Weber, H.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (17-18) : A41 - A42
  • [9] Mortality and length of hospital stay in patients receiving dobutamine, milrinone, or nesiritide for acute decompensated heart failure
    Arnold, LM
    Carroll, NV
    Oinonen, M
    Crouch, MA
    [J]. JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S103 - S103
  • [10] Effects of nesiritide and dobutamine on heart rate variability in patients with decompensated heart failure
    Aronson, D
    Horton, DP
    Burger, AJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 101A - 101A
12345